Inventor · disambiguated record
Hongwei Wu
Also filed as: WU HONGWEI
3 granted patents·7 pending applications·2 citations·filing 2003–2025
56Inventor score
Top patents by PatentIndex Score
10 records- 0179US11406646B2Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharideUNIV VIRGINIA COMMONWEALTH·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 0278US12226423B2Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharideUNIV VIRGINIA COMMONWEALTH·Filed 2022·Granted Feb 18, 2025·0 cites·20 claims
- 0366US2025249021A1Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic OligosaccharideUNIV VIRGINIA COMMONWEALTH·Filed 2025·Application pending·0 cites
- 0463US2022175798A1Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglycerideDURECT CORP·Filed 2021·Application pending·0 cites
- 0559US2021169902A1Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesionsUNIV VIRGINIA COMMONWEALTH·Filed 2020·Application pending·0 cites
- 0658US7115596B2Thiazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Granted Oct 3, 2006·1 cites·6 claims
- 0755US2019374554A1Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesionsUNIV VIRGINIA COMMONWEALTH·Filed 2017·Application pending·0 cites
- 0853US2020222430A1Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglycerideDURECT CORP·Filed 2017·Application pending·0 cites
- 0951US2019269695A1Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharideUNIV VIRGINIA COMMONWEALTH·Filed 2017·Application pending·0 cites
- 1043US2005043344A1Heteroarylalkanoic acids as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hongwei Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →